Flavonoid-Induced Ability of Minimally Modified Low-Density Lipoproteins to Support Lymphocyte Proliferation
- 1 April 1998
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 55 (7) , 1125-1129
- https://doi.org/10.1016/s0006-2952(97)00635-7
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The oxidation hypothesis of atherosclerosisThe Lancet, 1994
- Inhibition of Isoprenoid Biosynthesis Induces Apoptosis in Human Promyelocytic HL-60 CellsBiochemical and Biophysical Research Communications, 1994
- Changes in Iipoprotein(a), LDL‐cholesterol and apolipoprotein B in homozygous familial hypercholesterolaemic patients treated with dextran sulfate LDL‐apheresisEuropean Journal of Clinical Investigation, 1993
- Lipoprotein Oxidation and Measurement of Thiobarbituric Acid Reacting Substances Formation in a Single Microtiter Plate: Its Use for Evaluation of AntioxidantsAnalytical Biochemistry, 1993
- Quercetin prevents the cytotoxicity of oxidized LDL on lymphoid cell lines☆Free Radical Biology & Medicine, 1992
- Cytotoxicity of oxidized lipoproteinsCurrent Opinion in Lipidology, 1991
- Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophagesBiochemical Pharmacology, 1990
- Minimally modified low density lipoprotein stimulates monocyte endothelial interactions.Journal of Clinical Investigation, 1990
- Vitamin E content and low density lipoprotein oxidizability induced by free radicalsAtherosclerosis, 1990
- Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.Journal of Clinical Investigation, 1989